Lund University
New Blood Test Shows 90 Percent Accuracy in Diagnosing Alzheimer’s Disease
Developed by researchers from Lund University in Sweden, the test is more accurate than doctors’ diagnoses using standard clinical evaluation tools.
Qlucore Expands Into Bladder Cancer Diagnostics With Lund University Partnership
The company expects that this work to develop and validate classifier models for bladder cancer will lead to a CE mark for its Qlucore Diagnostics software platform.
Poor Endocrine Therapy Response in Primary Breast Cancer Possibly Explained by Rare ESR1 Mutations
Research reported at the AACR annual meeting suggests mutations in the estrogen receptor gene ESR1 in untreated primary breast cancers can influence endocrine treatment response.
Presence of B Cells in Tumors Associated With Favorable Immunotherapy Outcomes
Three new studies have found that the presence of B cells in tertiary lymphoid structures in tumors is associated with a favorable response to immunotherapy.